Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma

Pathology Research and Practice

Volumn 203, Issue 2, 2007, Pages 99-106

  Djordjevic, Gordana ^a   Mozetic, Vladimir ^b   Mozetic, Danijela Vrdoljak ^b   Licul, Vanja ^a   Ilijas, Koviljka Matusan ^a   Mustac, Elvira ^a   Oguic, Romano ^b   Fuckar, Zeljko ^b   Jonjic, Nives ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KBC RIJEKA   (Croatia)

Author keywords

Carcinoma; CD31; Renal cell; Survival rate; VEGF

Indexed keywords

ANTIBODY; KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STATISTICAL ANALYSIS; TISSUE PREPARATION; TUMOR CELL;

EID: 33846621588     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2006.12.002     Document Type: Article

References (41)

1. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Guidi A.J., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26 (1995) 86-91
2. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Manseau E.J., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 53 (1993) 4727-4735
3. Cornali E., Zietz C., Benelli R., Weninger W., Masiello L., et al. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J. Pathol. 149 (1996) 1851-1869
4. Dosquet C., Coudert M.C., Lepage E., Cabane J., and Richard F. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?. Clin. Cancer Res. 3 (1997) 2451-2458
5. Dvorak H.F., Sioussat T.M., Brown L.F., Berse B., Nagy J.A., et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 174 (1991) 1275-1278
6. WHO. Classification of Tumors, Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon
7. Eisen T., Boshoff C., Mak T I., Sapunar F., Vaughan M.M., et al. Continuous low dose thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. Br. J. Cancer 82 (2000) 812-817
8. Ferrara N., and Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161 (1989) 851-858
9. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285 (1971) 1182-1186
10. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 6 (1982) 655-663
11. Greenlee R.T., Murray T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J. Clin. 50 (2000) 7-33
12. Gunningham S.P., Currie M.J., Han C., Robinson B.A., Scott P.A., et al. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. J. Pathol. 193 (2001) 325-332
13. Hatva E., Bohling T., Jaaskelainen J., Persico M.G., Haltia M., and Alitalo K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am. J. Pathol. 148 (1996) 763-775
14. Herbst C., Kosmehl H., Stiller K.J., Berndt A., Eiselt M., et al. Evaluation of microvessel density by computerised image analysis in human renal cell carcinoma. J. Cancer Res. Clin. Oncol. 124 (1998) 141-147
15. Kirkali Z., and Obek C. Clinical aspects of renal cell carcinoma. EAU Update Ser. 1 (2003) 189-196
16. Kohler H.H., Barth P.J., Siebel A., Gerharz E.W., and Bittinger A. Quantitative assessment of vascular surface density in renal cell carcinomas. Br. J. Urol. 77 (1996) 650-654
17. Lissoni P., Fumagalli L., Giani L., Rovelli F., Confalonieri G., and Pescia S. Vascular endothelial growth factor (VEGF) serum levels during cancer immunotherapy with IL-2: preliminary consideration. Int. J. Biol. Markers 13 (1998) 98-101
18. MacLennan G.T., and Bostwick D.G. Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 46 (1995) 27-30
19. Matsumoto K., Suzuki K., Koike H., Okamura K., Tsuchiya K., et al. Prognostic significance of placental growth factor levels in renal cell cancer; an association with clinical characteristics and vascular endothelial growth factor levels. Anticancer Res. 23 (2003) 4953-4958
20. Minardi D., Lucarini G., Mazzucchelli R., Milanese G., Natali D., et al. Prognostic role of Fuhrman grade and vascular endothelial growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens. J. Urol. 174 (2005) 1208-1212
21. Nakagawa M., Emoto A., Hanada T., Nasu N., and Nomura Y. Tubulogenesis by microvascular endothelial cells is mediated by vascular endothelial growth factor (VEGF) in renal cell carcinoma. Br. J. Urol. 79 (1997) 681-687
22. Negrier S., Perol D., Menetrier-Caux C., Escudier B., Pallardy M., et al. Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6 - from the Groupe Français d'Immunothérapie. J. Clin. Oncol. 22 12 (2004) 2371-2378
23. Nicol D., Hii S.I., Walsh M., Teh B., Thompson L., et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. J. Urol. 157 (1997) 1482-1486
24. Nurmi M.J. Prognostic factors in renal carcinoma. An evaluation of operative findings. Br. J. Urol. 56 (1984) 270-275
25. Potgens A.J., Lubsen N.H., van Altena M.C., Schoenmakers J.G., Ruiter D.J., and de Waal R.M. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice. Am. J. Pathol. 146 (1995) 197-209
26. Samoto K., Ikezaki K., Ono M., Shono T., Kohno K., et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 55 (1995) 1189-1193
27. Sillman F., Boyce J., and Fruchter R. The significance of atypical vessels and neovascularization in cervical neoplasia. Am. J. Obstet. Gynecol. 139 (1981) 154-159
28. Sivridis E., Giatromanolaki A., and Koukourakis M.I. The vascular network of tumours - what is not for?. J. Pathol. 201 (2003) 173-180
29. (2002), Wiley, New York
30. Srivastava A., Laidler P., Davies R.P., Horgan K., and Hughes L.E. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am. J. Pathol. 133 (1988) 419-423
31. Stadler W.M., Kuzel T., Shapiro C., Sosman J., Clark J., and Vogelzang N.J. Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma. J. Clin. Oncol. 17 (1999) 2541-2545
32. Strohmeyer D. Pathophysiology of tumour angiogenesis and its relevance in renal cell cancer. Anticancer Res. 19 (1999) 1557-1561
33. Takano S., Yoshii Y., Kondo S., Suzuki H., Maruno T., et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56 (1996) 2185-2190
34. Verheul H.M., Voest E.E., and Schlingemann R.O. Are tumours angiogenesis-dependent?. J. Pathol. 202 (2004) 5-13
35. Wechsel H.W., Bichler K.H., Feil G., Loeser W., Lahme S., and Petri E. Renal cell carcinoma: relevance of angiogenetic factors. Anticancer Res. 19 (1999) 1537-1540
36. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 324 (1991) 1-8
37. Yang C.C., Chu K.C., and Yeh W.M. Expression of vascular endothelial growth factor in renal cell carcinoma is correlated with cancer advancement. J. Clin. Lab. Anal. 17 (2003) 85-89
38. Yildiz E., Gokce G., Kilicarslan H., Ayan S., Goze O.F., and Gultekin E.Y. Prognostic value of the expression of Ki67, CD44 and vascular endothelial growth factor and microvessel invasion in renal cell carcinoma. BJU Int. 93 (2004) 1087-1093
39. Yoshino S., Kato M., and Okada K. Prognostic significance of microvessel count in low stage renal cell carcinoma. Int. J. Urol. 2 (1995) 156-160
40. Yoshino S., Kato M., and Okada K. Evaluation of the prognostic significance of microvessel count and tumour size in renal cell carcinoma. Int. J. Urol. 5 (1998) 119-123
41. Yoshino S., Kato M., and Okada K. Clinical significance of angiogenesis, proliferation and apoptosis in renal cell carcinoma. Anticancer Res. 20 (2000) 591-594